Not provided
Not provided
Not provided
Not provided
Not provided
Lack of funding
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to determine if a post-operative course of oral dexamethasone affects opioid usage in pediatric patients undergoing tonsillectomy.
Patients who are scheduled to undergo tonsillectomy or adenotonsillectomy are randomized to receive either 1) a post-operative steroid course of oral dexamethasone in addition opioids, acetaminophen,NSAIDs or 2) opioids/acetaminophen/NSAIDS alone. All drugs are prescribed per approved FDA labeling. Children between the ages of 4-17 will be considered for enrollment.
Participants (or with the aid of parents/legal guardian for subjects unable to complete on their own) will complete a diary twice a day to record pain medication administration and visual pain scale. Remaining steroid and opioid medication will be measured at the routine post-operative appointment that occurs 4 - 6 weeks following surgery.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Dexamethasone plus analgesics | Experimental | oral dexamethasone of 0.5mg/kg/day (max of 8mg/day), administered on post-operative days 1,3,5,7 in addition to standardized course of analgesics (opioids/acetaminophen/NSAIDs). |
|
| analgesics alone | Active Comparator | standardized course of analgesics (opioids/acetaminophen/NSAIDs) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Dexamethasone | Drug | dexamethasone solution or tablet (depending on age of patient) at 0.5mg/kg/day max of 8mg/day, administered on post-operative days 1,3,5,7. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Opioid Use (Number of Doses) | Measured by medication log and units remaining. | 4 weeks post-op |
| Average Pain Score | Measured by a visual analog scale, where 0 is no pain and 10 is worst possible pain. | 14 days post-op |
| Measure | Description | Time Frame |
|---|---|---|
| Number of Participants With Post-operative Complications | Post-op re-admissions and emergency room visits. | 30 days post-op |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Eileen Raynor, MD | Duke Health | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Duke University Medical Center and affiliated practices | Durham | North Carolina | 27710 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Dexamethasone Plus Analgesics | oral dexamethasone of 0.5mg/kg/day (max of 8mg/day), administered on post-operative days 1,3,5,7 in addition to standardized course of analgesics (opioids/acetaminophen/NSAIDs). Dexamethasone: dexamethasone solution or tablet (depending on age of patient) at 0.5mg/kg/day max of 8mg/day, administered on post-operative days 1,3,5,7. Analgesics: standardization of post-operative analgesics (narcotics and non-narcotic medication).
|
| FG001 | Analgesics Alone | standardized course of analgesics (opioids/acetaminophen/NSAIDs) Analgesics: standardization of post-operative analgesics (narcotics and non-narcotic medication).
|
| Title | Milestones | Reasons Not Completed | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Dexamethasone Plus Analgesics | oral dexamethasone of 0.5mg/kg/day (max of 8mg/day), administered on post-operative days 1,3,5,7 in addition to standardized course of analgesics (opioids/acetaminophen/NSAIDs). Dexamethasone: dexamethasone solution or tablet (depending on age of patient) at 0.5mg/kg/day max of 8mg/day, administered on post-operative days 1,3,5,7. Analgesics: standardization of post-operative analgesics (narcotics and non-narcotic medication).
|
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Mean |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Opioid Use (Number of Doses) | Measured by medication log and units remaining. | Participants who completed the study. | Posted | Mean | Standard Deviation | doses | 4 weeks post-op |
|
Up to 30 days post-op
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Dexamethasone Plus Analgesics | oral dexamethasone of 0.5mg/kg/day (max of 8mg/day), administered on post-operative days 1,3,5,7 in addition to standardized course of analgesics (opioids/acetaminophen/NSAIDs). Dexamethasone: dexamethasone solution or tablet (depending on age of patient) at 0.5mg/kg/day max of 8mg/day, administered on post-operative days 1,3,5,7. Analgesics: standardization of post-operative analgesics (narcotics and non-narcotic medication).
|
Not provided
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Emergency Room Visit | General disorders | Non-systematic Assessment |
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Eileen M. Raynor, MD | Duke University | 919-613-4573 | eileen.raynor@duke.edu |
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Oct 5, 2023 | Dec 4, 2024 | Prot_SAP_000.pdf |
Not provided
| ID | Term |
|---|---|
| D010149 | Pain, Postoperative |
| ID | Term |
|---|---|
| D011183 | Postoperative Complications |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D010146 | Pain |
Not provided
Not provided
| ID | Term |
|---|---|
| D003907 | Dexamethasone |
| D000700 | Analgesics |
| ID | Term |
|---|---|
| D011246 | Pregnadienetriols |
| D011245 | Pregnadienes |
| D011278 | Pregnanes |
| D013256 | Steroids |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Analgesics | Drug | standardization of post-operative analgesics (narcotics and non-narcotic medication).
|
|
| BG001 | Analgesics Alone | standardized course of analgesics (opioids/acetaminophen/NSAIDs) Analgesics: standardization of post-operative analgesics (narcotics and non-narcotic medication).
|
| BG002 | Total | Total of all reporting groups |
| years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Ethnicity (NIH/OMB) | Count of Participants | Participants |
|
| Race/Ethnicity, Customized | Count of Participants | Participants |
|
| Region of Enrollment | Count of Participants | Participants |
|
| OG001 | Analgesics Alone | standardized course of analgesics (opioids/acetaminophen/NSAIDs) Analgesics: standardization of post-operative analgesics (narcotics and non-narcotic medication).
|
|
|
|
| Primary | Average Pain Score | Measured by a visual analog scale, where 0 is no pain and 10 is worst possible pain. | Participants who completed the study. | Posted | Mean | Standard Deviation | score on a scale | 14 days post-op |
|
|
|
|
| Secondary | Number of Participants With Post-operative Complications | Post-op re-admissions and emergency room visits. | Participants who completed the study. | Posted | Count of Participants | Participants | 30 days post-op |
|
|
|
|
| 0 |
| 16 |
| 0 |
| 16 |
| 12 |
| 16 |
| EG001 | Analgesics Alone | standardized course of analgesics (opioids/acetaminophen/NSAIDs) Analgesics: standardization of post-operative analgesics (narcotics and non-narcotic medication).
| 0 | 8 | 0 | 8 | 6 | 8 |
| Bleeding | Injury, poisoning and procedural complications | Non-systematic Assessment |
|
| Nausea/Vomiting | Gastrointestinal disorders | Non-systematic Assessment |
|
| Sleep Disturbance/Insomnia | General disorders | Non-systematic Assessment |
|
| Fever | General disorders | Non-systematic Assessment |
|
| Constipation | Gastrointestinal disorders | Non-systematic Assessment |
|
| Other - not specified | General disorders | Non-systematic Assessment |
|
Not provided
Not provided
Not provided
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D000072473 |
| Fused-Ring Compounds |
| D011083 | Polycyclic Compounds |
| D013259 | Steroids, Fluorinated |
| D018689 | Sensory System Agents |
| D018373 | Peripheral Nervous System Agents |
| D045505 | Physiological Effects of Drugs |
| D020228 | Pharmacologic Actions |
| D020164 | Chemical Actions and Uses |
| D002491 | Central Nervous System Agents |
| D045506 | Therapeutic Uses |